scispace - formally typeset
H

Hormuzd A. Katki

Researcher at National Institutes of Health

Publications -  201
Citations -  12020

Hormuzd A. Katki is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 49, co-authored 182 publications receiving 10157 citations. Previous affiliations of Hormuzd A. Katki include Kaiser Permanente & University of Alabama at Birmingham.

Papers
More filters
Journal ArticleDOI

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors

TL;DR: The group’s goal was to provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screening tests, cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS) following adoption of cervical cancer screenings guidelines incorporating longer screening intervals and co-testing.
Journal ArticleDOI

Selection criteria for lung-cancer screening.

TL;DR: The use of the PLCO(M2012) model was more sensitive than the NLST criteria for lung-cancer detection and compared the accuracy of PLCo(M 2012) criteria withNLST criteria to detect lung cancer.
Journal ArticleDOI

Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis

TL;DR: Analyzing data from over 650,000 individuals, Dr. Steven Moore and colleagues report that greater amounts of leisure-time physical activity were associated with higher life expectancy across a wide range of activity levels and body mass index groups.
Journal ArticleDOI

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

TL;DR: For women aged 30 years and older in routine clinical practice who are negative by co-testing (both HPV and cytology), 3-year screening intervals were safe because a single negative test for HPV was sufficient to reassure against cervical cancer over 5 years.
Journal ArticleDOI

Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death

TL;DR: Screening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk.